— Know what they know.
Not Investment Advice

AXGN NASDAQ

AxoGen, Inc.
1W: -13.8% 1M: -22.6% 3M: -18.7% YTD: +20.6% 1Y: +109.2% 3Y: +647.8% 5Y: +132.4%
$37.39
-2.53 (-6.34%)
 
Weekly Expected Move ±8.2%
$31 $34 $37 $40 $44
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 36 · $2.0B mcap · 52M float · 2.35% daily turnover · Short 67% of daily vol

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-01-31
Earliest Filing
2022-08-25
Latest Filing
supplier: 2 partner: 1

Counterparties (Filed by AXGN)

3 relationships

Companies named in AXGN's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Ja-Cole, L.P. — supplier Landlord providing additional leased premises for distribution and storage. 2022-08-25 View
Community Blood Center — supplier Service provider for tissue processing, sterilization, and office support. 2022-08-25 View
Ja-Cole, L.P. — partner Commercial lease amendment for office and warehouse space in Burleson, Texas. 2022-01-31 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-01 Regulation FD; Exhibits View
2026-09-10 Material Agreement; Regulation FD; Other Events; Exhibits Agreement View
2026-09-10 Material Agreement; Regulation FD; Exhibits Agreement View
2026-07-29 Earnings Release; Regulation FD; Exhibits View
2026-06-23 Shareholder Vote View
2026-04-28 Earnings Release; Regulation FD; Exhibits View
2026-02-24 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2026-01-23 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2026-01-12 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-12-05 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-12-04 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-10-29 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-08-25 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-08-05 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-06-20 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-05-08 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-04-07 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-03-04 Regulation FD Disclosure View
2025-02-25 Results of Operations and Financial Condition; Regulation FD Disclosure View
2025-01-10 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms